Moderna Gets $590 Million in Federal Funding

CDC officials say medical professionals are seeing more patients whose illness cannot be traced back to an infected animal or ...
Moderna's stock is down 36.63% due to poor COVID-19 vaccine sales and lack of promising alternatives, but bird flu presents asymmetric upside potential. The company's cost-cutting measures may ...